This content is from: Patents

In-house IP roundup – Generics say SPC Waiver will save money but increase litigation, counsel share M&A tips

Patent Strategy, a new service from Managing IP, rounds up the latest news and analysis from patent-focused businesses

SPC man

Generics: SPC Waiver will save money but increase litigation

Fresenius Kabi, Insud Pharma and other generic drug firms explain how the EU’s SPC manufacturing waiver in its compromised form will benefit them – but also how its notification clause could make litigation easier and more attractive to innovator drug companies. (Read more … )

chain

In-house counsel share M&A due diligence tips

Uber, Nestlé and a luggage company speak to Patent Strategy about their due diligence difficulties during mergers and acquisitions and how they avoid the inherent portfolio analysis pitfalls. (Read more … )

Sign up to receive more content like this in Patent Strategy’s weekly newsletter.

The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.

© 2020 Euromoney Institutional Investor PLC. For help please see our FAQs.

Instant access to all of our content. Membership Options | One Week Trial